about
Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in modelSmall ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregationPeripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy.Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant proteinMacroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice.Clinical features of spinal and bulbar muscular atrophy.Kennedy's disease: pathogenesis and clinical approaches.Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man.Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.Mendelian genetics of male infertilityAltered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice.Rescue of Metabolic Alterations in AR113Q Skeletal Muscle by Peripheral Androgen Receptor Gene Silencing.The role of androgen receptor mutations in prostate cancer progression.Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.The unfolded protein response modulates toxicity of the expanded glutamine androgen receptor.Short tandem repeat polymorphism linkage to the androgen receptor gene in prostate carcinoma.Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts.New treatments for denervating diseases.Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.A phenotypic-genetic study of a group of Polish patients with spinal and bulbar muscular atrophy.Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway.
P2860
Q24673304-10684723-CCB0-455B-BDBF-201FB4A208B5Q30377831-3EFBCDE3-1471-4FF6-B894-F78917E8F878Q30405294-93AA2441-2611-4158-A047-888531ED4B3DQ30445140-49C78943-B6F2-4022-8551-1DCA6E8F973DQ34055364-1F422F4B-3C63-4594-A18F-5311AAF6C9CDQ35008921-D18B8971-A4E2-4438-93F6-7BEB09B97AC4Q35777504-548B63D8-E6F5-471D-93FE-A1A9BA696BC4Q36371585-9A4AE5A1-200F-46EC-A313-B641FB63A3ADQ36759577-684376A2-2ED0-4E57-978F-C89E7771100AQ36846121-29B43369-1954-4F6A-8EE0-EFA7A6E279C8Q37331263-E3B7EAE8-FB3B-401F-8275-98930F657CA3Q37361212-CE95FBD7-E61A-4AB9-875C-757E359ADB03Q37590123-C8C45D61-CDF4-4141-90A0-748AE306E7F4Q37791489-3BB08F4F-AF9E-4754-96A3-51AA778E1CFBQ38328680-6FA6F41B-0EE7-4967-AAC5-47C545C20EECQ43824290-DC0F206E-2E32-479D-90EF-B477227FED22Q44690065-C4D7919E-0582-4302-BBD0-76B6D79DB449Q46439343-98AAEB72-5636-4BD9-ABC5-0EB7EA374B69Q46765808-25397B47-7962-4353-BD59-E4AE061400FDQ50278416-13E0332D-5787-43FB-B59E-725E953F158CQ53173112-2C430E31-FBD9-49B5-941C-76F2EC20FA88
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Triplet repeat expansion in neuromuscular disease.
@ast
Triplet repeat expansion in neuromuscular disease.
@en
type
label
Triplet repeat expansion in neuromuscular disease.
@ast
Triplet repeat expansion in neuromuscular disease.
@en
prefLabel
Triplet repeat expansion in neuromuscular disease.
@ast
Triplet repeat expansion in neuromuscular disease.
@en
P2860
P1433
P1476
Triplet repeat expansion in neuromuscular disease.
@en
P2093
Fischbeck KH
Lieberman AP
P2860
P304
P356
10.1002/(SICI)1097-4598(200006)23:6<843::AID-MUS2>3.0.CO;2-8
P577
2000-06-01T00:00:00Z